QuickBird Medical
  • Case Studies
    • Case Studies
    • Customers
  • Services
    • Development: DiGA
    • Development: Medical Software
    • Development: Health Apps
    • Development: Decision Support Systems
    • Development: Wearables for Medical Devices
    • Legal Manufacturer for Medical Devices
    • BSI TR-03161 for DiGA
    • Support for your Software Team
    • Further Services
  • Insights
  • About us
    • Team
    • Jobs
  • Contact
  • German
Select Page
DiGA: Guidelines for demonstrating positive supply effects

DiGA: Guidelines for demonstrating positive supply effects

by Alexander Fenkiw | Jun 18, 2021 | Unkategorisiert

 What is the point of a DiGA if it does not improve patients’ lives? There is none! This is why DiGAs are only justified when their positive supply effect has been proven. Only then do you have a chance of being permanently included in the BfArM register....

Insider-Empfehlungen für DiGA-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper

Insider-Empfehlungen für Software-Medizinprodukt-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper


Sie planen eine Medical Software oder DiGA?

Sprechen Sie mit unserem Geschäftsführer Malte Bucksch

+49 (0) 89 54998380
kontakt@quickbirdmedical.com
Kontakt

+49 (0) 89 54998380
kontakt@quickbirdmedical.com

 

Whitepaper

13 wichtige Empfehlungen für angehende DiGA-Hersteller 2025

13 wichtige Empfehlungen für angehende Medizinprodukt-Hersteller 2025

Aktuelles

DiGA- und Medical Software-Newsletter

Digital Health Events 2025

Presse – QuickBird in den Medien

© 2025 Impressum | Datenschutz